Family Medicine Doctors in Seagoville, TX Accepting Medicare
1 Family Medicine doctors found. Showing 1 - 1
 Cora L Alexander, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 Hall Rd, Seagoville, TX 75159 Phone: 972-287-7474 Fax: 972-228-7746 |
News Archive
Healogics to take part in campaign highlighting link between diabetes and chronic wounds
Healogics, the nation's wound healing expert, is proud to participate in a national diabetes awareness campaign October 29 through November 2. This campaign will highlight the important connection between diabetes and chronic wounds and their recurrence.
Prenatal exposure to industrial and environmental pollutants probably causes most childhood cancers
Most childhood cancers are "probably" down to prenatal exposure to industrial and environmental pollutants, most likely to have been inhaled by the mother during pregnancy, suggests research in the Journal of Epidemiology and Community Health.
Latanoprost is safe as adjunctive therapy for long-term treatment of common form of glaucoma
Glaucoma is a condition in which the pressure inside the eyes rises. If untreated, glaucoma may damage the optic nerve and other parts of the eye, and my lead to blindness. According to information in the article, latanoprost is a derivative of the chemical prostaglandin F2-alpha. Prostaglandin derivatives have been shown to help lower intraocular pressure (IOP).
New article provides guidance on managing critically ill patients at risk for alcohol withdrawal
Alcohol withdrawal adds challenges to caring for critically ill patients, and nurses must be diligent at each stage of care to minimize complications, according to an article in the February issue of Critical Care Nurse.
CardioNova initiates Phase 1b clinical trial with AtheroNova's AHRO-001
AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001.
› Verified 9 days ago